Evaluation of Mesoridazine. (Serentil).
D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D007273:Injections, Intramuscular; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011187:Posture; D011247:Pregnancy; D012559:Schizophrenia / Q000188:drug therapy
D010640:Phenothiazines